QuartataWeb
Home  |   About  |   Theory  |   Tutorials  |   FAQ  |   Bahar Lab  |   Statistics

 

Network of interactions between drugs (red spheres) and targets (blue spheres) is displayed above.
The red lines are used for the predicted interactions and the thickness of edges indicate the confidence score of predictions.


12 known interactions (drugs) of input target (CASP3): Caspase-3
No. Group Type Drug ID Drug Name SMILES
⇨ TargetHunter
Image
1 Experimental SmallMoleculeDrug DB08251 4-[5-(2-CARBOXY-1-FORMYL-ETHYLCARBAMOYL)-PYRIDIN-3-YL]-BENZOIC ACID Thumb
2 Experimental SmallMoleculeDrug DB03124 5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid Thumb
3 Experimental SmallMoleculeDrug DB06862 2-HYDROXY-5-(2-MERCAPTO-ETHYLSULFAMOYL)-BENZOIC ACID Thumb
4 Experimental SmallMoleculeDrug DB08497 (1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate Thumb
5 Approved;
Investigational
SmallMoleculeDrug DB01017 Minocycline Thumb
6 Approved;
Experimental
SmallMoleculeDrug DB13751 Glycyrrhizic acid Thumb
7 Investigational SmallMoleculeDrug DB05408 Emricasan Thumb
8 Experimental SmallMoleculeDrug DB08213 1-METHYL-5-(2-PHENOXYMETHYL-PYRROLIDINE-1-SULFONYL)-1H-INDOLE-2,3-DIONE Thumb
9 Experimental SmallMoleculeDrug DB07696 methyl (3S)-3-[(tert-butoxycarbonyl)amino]-4-oxopentanoate Thumb
10 Experimental SmallMoleculeDrug DB08499 N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide Thumb
11 Experimental SmallMoleculeDrug DB08229 [N-(3-DIBENZYLCARBAMOYL-OXIRANECARBONYL)-HYDRAZINO]-ACETIC ACID Thumb
12 Experimental SmallMoleculeDrug DB08498 (1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate Thumb


20 predicted interactions (drugs) of input target (CASP3): Caspase-3
No. Group Type Drug ID Drug Name SMILES
⇨ TargetHunter
Image Confidence score
1 Approved;
Investigational
SmallMoleculeDrug DB12010 Fostamatinib Thumb 30.7%
2 Approved;
Investigational
SmallMoleculeDrug DB01593 Zinc Thumb 28.8%
3 Investigational SmallMoleculeDrug DB05767 Andrographolide Thumb 27.4%
4 Approved SmallMoleculeDrug DB00675 Tamoxifen Thumb 25.8%
5 Approved BiotechDrug DB10770 Foreskin fibroblast (neonatal) Thumb 25.3%
6 Approved;
Investigational
SmallMoleculeDrug DB01296 Glucosamine Thumb 25.2%
7 Approved SmallMoleculeDrug DB02659 Cholic Acid Thumb 25.2%
8 Experimental SmallMoleculeDrug DB01972 Guanosine-5'-Monophosphate Thumb 24.5%
9 Investigational SmallMoleculeDrug DB04869 Olcegepant Thumb 24.4%
10 Approved;
Investigational;
Withdrawn
SmallMoleculeDrug DB01041 Thalidomide Thumb 24.2%
11 Experimental SmallMoleculeDrug DB02379 Beta-D-Glucose Thumb 24.2%
12 Experimental SmallMoleculeDrug DB04447 1,4-Dithiothreitol Thumb 23.7%
13 Investigational SmallMoleculeDrug DB05507 VX-765 Thumb 23.5%
14 Approved;
Investigational;
Vet approved
SmallMoleculeDrug DB13953 Estradiol benzoate Thumb 22.6%
15 Experimental SmallMoleculeDrug DB08848 Guvacine Thumb 21.5%
16 Experimental SmallMoleculeDrug DB04464 N-Formylmethionine Thumb 21.3%
17 Investigational;
Nutraceutical
SmallMoleculeDrug DB00171 ATP Thumb 20.5%
18 Approved;
Investigational
SmallMoleculeDrug DB11703 Acalabrutinib Thumb 20.0%
19 Experimental SmallMoleculeDrug DB06834 N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide Thumb 20.0%
20 Approved;
Investigational
SmallMoleculeDrug DB06439 Tyloxapol Thumb 19.9%



  logl

Reference:  Hongchun Li, Fen Pei, D. Lansing Taylor and Ivet Bahar. (2020) QuartataWeb: Integrated Chemical–Protein-Pathway Mapping for Polypharmacology and Chemogenomics. Bioinformatics 36(12), 3935–3937.

Contact:

The QuartataWeb server is maintained by the Bahar Lab at the Department of Computational & Systems Biology at the University of Pittsburgh, School of Medicine, and sponsored by the NIH awards P41 GM103712 and P01 DK096990; and by the Li Lab at Research Center for Computer-Aided Drug Discovery at Shenzhen Institutes of Advanced Technology, CAS.

For questions and comments please contact Hongchun Li.